Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.81
-
NAV
₹510.69
-
Fund Started
10 May 2004
-
Fund Size
₹7875.40 Cr
-
Exit Load
Exit load of 1% if redeemed within 1 month.
-
1 Year
9.01%
-
3 Year
23.77%
-
5 Year
15.54%
-
Equity
98.96%
-
Cash
1.04%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.67% |
Lupin Ltd. | 7.88% |
Divi's Laboratories Ltd. | 6.54% |
Dr. Reddy's Laboratories Ltd. | 6.06% |
Cipla Ltd. | 5.88% |
Apollo Hospitals Enterprise Ltd. | 5.73% |
Medplus Health Services Ltd. | 3.68% |
Vijaya Diagnostic Centre Ltd. | 3.51% |
Ajanta Pharma Ltd. | 3.39% |
Glaxosmithkline Pharmaceuticals Ltd. | 2.78% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
-
Launch Date
10 May 2004
-
